A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

B ERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...

Researchers identified immune cells that attacked the neuronal protein C9orf72 in individuals with ALS, spurring new ...

The prize honored discoveries that defined peripheral immune tolerance through regulatory T cells (Tregs) and the FOXP3 gene, ...

Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...

CAR T-cell therapy was first developed as a lymphoma treatment but has recently been applied to autoimmune diseases, primarily lupus, systemic sclerosis, and myositis. Up to this point, ulcerative ...

Researchers at Cincinnati Children’s Hospital Medical Center, in collaboration with Roche, have developed a next-generation ...